Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J A Duncan

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|January 25, 2025
Antibody testing to predict SARS-CoV-2 risk in immunocompromised peopleChristopher J A Duncan
The Journal of Infection|April 29, 2015
Varicella zoster virus immunity: A primerChristopher J A Duncan, Sophie Hambleton
Clinical Medicine (London, England)|December 4, 2014
Host genetic factors in susceptibility to mycobacterial diseaseChristopher J A Duncan, Sophie Hambleton
Viruses|December 14, 2011
Viral determinants of HIV-1 macrophage tropismChristopher J A Duncan, Quentin J Sattentau
Frontiers in Immunology|December 5, 2019
Microglia Are Essential to Protective Antiviral Immunity: Lessons From Mouse Models of Viral EncephalitisCatherine F Hatton, Christopher J A Duncan
The American Journal of Tropical Medicine and Hygiene|April 12, 2012
Controlled human blood stage malaria infection: current status and potential applicationsChristopher J A Duncan, Simon J Draper
BMJ (Clinical Research Ed.)|December 15, 2011
What is the efficacy of the RTS,S malaria vaccine?Christopher J A Duncan, Adrian V S Hill
BMJ (Clinical Research Ed.)|October 5, 2012
Improving targeted screening for hepatitis C in the UKChristopher J A Duncan, Ewen Stewart, Ray Fox
BMJ (Clinical Research Ed.)|May 16, 2012
Tick bite and early Lyme borreliosisChristopher J A Duncan, George Carle, R Andrew Seaton
Vaccine|October 22, 2013
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodiesTorben Schiffner, Quentin J Sattentau, Christopher J A Duncan
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|January 25, 2025
Antibody testing to predict SARS-CoV-2 risk in immunocompromised peopleChristopher J A Duncan
The Journal of Infection|April 29, 2015
Varicella zoster virus immunity: A primerChristopher J A Duncan, Sophie Hambleton
Clinical Medicine (London, England)|December 4, 2014
Host genetic factors in susceptibility to mycobacterial diseaseChristopher J A Duncan, Sophie Hambleton
Viruses|December 14, 2011
Viral determinants of HIV-1 macrophage tropismChristopher J A Duncan, Quentin J Sattentau
Frontiers in Immunology|December 5, 2019
Microglia Are Essential to Protective Antiviral Immunity: Lessons From Mouse Models of Viral EncephalitisCatherine F Hatton, Christopher J A Duncan
The American Journal of Tropical Medicine and Hygiene|April 12, 2012
Controlled human blood stage malaria infection: current status and potential applicationsChristopher J A Duncan, Simon J Draper
BMJ (Clinical Research Ed.)|December 15, 2011
What is the efficacy of the RTS,S malaria vaccine?Christopher J A Duncan, Adrian V S Hill
BMJ (Clinical Research Ed.)|October 5, 2012
Improving targeted screening for hepatitis C in the UKChristopher J A Duncan, Ewen Stewart, Ray Fox
BMJ (Clinical Research Ed.)|May 16, 2012
Tick bite and early Lyme borreliosisChristopher J A Duncan, George Carle, R Andrew Seaton
Vaccine|October 22, 2013
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodiesTorben Schiffner, Quentin J Sattentau, Christopher J A Duncan
Pageof 9